Founders

Guenther Karmann, Ph.D

 

Guenther Karmann, Ph.D

 

Guenther is a seasoned Pharmaceutical Researcher with successful career at Bayer AG culminating as the Biotechnology Department Head and led to his appointment as the CEO of DeveloGen AG.

 

Guenther has over 25 years of experience in therapeutic research in cardiovascular diseases, diabetes (type 1 and type 2) and cancer.  Working in three different continents, Guenther has been head of Biotechnological groups of up to 180 people. For 15 years Guenther has been leading Bayer to discovery of new target molecules for therapeutic interventions, target identification with genomics and bioinformatics and enabling technologies encompassing biology and chemistry. He also built a business segment “Cancer”, identified strategic partners and sealed collaborations with pharmaceutical companies.

 

Through management of external collaborations with a budget close to $6M, the cancer research group lead by Guenther presented its first development candidate.